A KLH conjugated synthetic peptide selected from the center region of Human UGT2B17.
Our Abpromise guarantee covers the use of ab92610 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ICC/IF||Use a concentration of 5 µg/ml.|
|WB||1/50 - 1/100. Predicted molecular weight: 61 kDa.Can be blocked with UGT2B17 peptide (ab156833).|
ab92610 has not yet been referenced specifically in any publications.